Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	6.42B
Revenue (ttm)	6.19B
Net Income (ttm)	358.65M
Shares Out	85.00M
EPS (ttm)	4.22
PE Ratio	17.89
Forward PE	15.97
Dividend	1.25 (1.66%)
Ex-Dividend Date	Feb 11, 2025

Volume	101,104
Average Volume	148,497
Open	75.30
Previous Close	75.30
Day's Range	74.90 - 75.60
52-Week Range	74.80 - 119.80
Beta	0.11
RSI	31.48
Earnings Date	Mar 20, 2025

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marke...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2023, TADAWUL:4163's revenue was 5.74 billion, an increase of 6.87% compared to the previous year's 5.37 billion. Earnings were 329.22 million, an increase of 7.78%.